Water has many unique properties. An interdisciplinary team of Waterloo scientists has discovered a one-dimensional chain of water molecules could produce a quantum phase transition. This breakthrough is a key development for future water-based quantum devices.
Dr. Scott Taylor has been awarded the Bernard Belleau Award from the Chemical Insitute of Canada for his contributions to medicinal chemistry.
Dr. Thomas Jennewein has his sights set high and wide — specifically on a quantum satellite orbiting high above the Earth to connect Canada and Europe via a secure quantum communication link. A new HyperSpace collaboration envisions secure quantum connections across the Atlantic Ocean.
Waterloo’s globally recognized startup program Velocity launched an initiative – Velocity Health – that aims to help new companies in the health-tech sector access funding and get products and services in the hands of those who need them.
ChatGPT, a language processing tool driven by artificial intelligence (AI), has been making headlines since its launch late last year. Now it will help train pharmacists for the future.
The University of Waterloo was awarded nearly $10 million in federal funding yesterday for a major initiative to rebuild Canada's pandemic-battered aeronautics sector and position it for a more sustainable future.
The Department of Earth and Environmental Sciences is mourning the passing of Dr. Paul Karrow. He was a founding member and the first Chair of the Department. Karrow passed away on February 5, 2023 at the age of 93.
Darren Harry Baine is a University of Waterloo undergrad and entrepreneur passionate about inspiring youth to think beyond themselves and create initiatives that advance society.
Recognizing the need for transformative solutions in an evolving healthcare landscape, Velocity is building a globally competitive platform for startups to commercialize health technology. The expansion provides world-class support to even more health startups in Canada and will be led by Science alumnus Moazam Khan.
Waterloo School of Pharmacy researchers have found that in patients with type-2 diabetes experiencing severe hypoglycaemic events, where blood glucose levels fall below normal to potentially dangerous levels leading to either a hospitalization or physician visit, is consistently linked with the development of dementia.